Canada’s largest publicly traded producer of medical marijuana is making the case for the quality of weed made by large-scale manufacturers compared to homegrown bud.
The difference is the same as drinking homebrew versus a good bottle of wine, Bruce Linton, chairman and CEO of Canopy Growth Corp. (TSXV:CGC), said Thursday during a call with analysts.
“People say: ‘It’s just soil, it grows easily,”‘ he said.
“No, no, no — quality and consistency doesn’t happen without chemicals unless you’re running a proper facility.”
– Read the entire article at CTV News.